NCT07152379View on ClinicalTrials.gov

Challenge Transfusion of INTERCEPT Pathogen Reduced Red Blood Cells (RBCs) in Subjects With or Without Pre-existing Antibodies to INTERCEPT RBCs

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 1, 2026

Primary Completion Date

October 1, 2027

Study Completion Date

January 1, 2028

Conditions
Transfusion Reaction, Hemolytic
Interventions
DEVICE

INTERCEPT RBCs

Transfusion of fresh (≤14 days old) allogeneic INTERCEPT RBCs.

Sponsors

Lead Sponsor

Cerus Corporation
All Listed Sponsors
lead

Cerus Corporation

INDUSTRY